Department of Dermatology, University Hospitals of Schleswig-Holstein, University of Kiel, Germany.
Strahlenther Onkol. 2011 Jun;187(6):378-84. doi: 10.1007/s00066-011-2224-8. Epub 2011 May 16.
A side effect of radiotherapy for breast cancer is acute radiodermatitis. It is a common practice to keep irradiated skin dry on account of data from the 1950s that suggested this regimen limits dermatitis. However, severe dryness of the skin induced by irradiation results in itching and discomfort. Dry skin is characterized by scaliness, epidermal barrier dysfunction, and reduced stratum corneum hydration, and these signs and symptoms are reduced by treatment with an emulsion.
We performed a randomized, controlled, open-label study with 66 patients (ITT population), treating the irradiated skin in one group (n = 34) with an oil-in-water emulsion (WO1932), while leaving the other group untreated (n = 32). Clinical scoring (ONS radiation skin reaction scoring, pruritus) and biophysical measurements (stratum corneum hydration and transepidermal water loss (TEWL), as a marker of skin barrier function) were determined at day 1 (directly after termination of the radiation therapy), day 8, and day 47 (± 7).
Irradiation increased the ONS score and pruritus, whereas skin hydration and TEWL were reduced. The primary hypothesis that the increase in skin hydration was significantly greater in the emulsion-treated compared to the untreated group as early as after 8 days of treatment could not be confirmed. At the end of the study (day 47 ± 7), however, normalization of stratum corneum hydration was more advanced in the treatment group compared to the untreated group and nearly reached the values of the contralateral healthy breast skin. ONS score and pruritus also revealed an advantage for the emulsion-treated group. TEWL did not show significant changes during emulsion treatment. No adverse events were caused by the treatment regimens
Treatment of radiodermatitis with an oil-in-water emulsion was well tolerated, enhanced stratum corneum hydration, improved clinical indicators, and provided relief from itching.
乳腺癌放射治疗的副作用之一是急性放射性皮炎。根据 20 世纪 50 年代的数据,保持照射皮肤干燥可以限制皮炎,因此保持照射皮肤干燥是一种常见做法。然而,放射引起的皮肤严重干燥会导致瘙痒和不适。干性皮肤的特征是鳞屑、表皮屏障功能障碍和角质层水分减少,这些症状和体征通过乳液治疗得到改善。
我们对 66 名患者(意向治疗人群)进行了一项随机、对照、开放标签研究,一组患者(n=34)接受水包油乳剂(WO1932)治疗,另一组患者(n=32)未接受治疗。在第 1 天(直接结束放射治疗后)、第 8 天和第 47 天(±7 天),对临床评分(ONS 放射性皮肤反应评分、瘙痒)和生物物理测量(角质层水分和经皮水分丢失(TEWL),作为皮肤屏障功能的标志物)进行了测定。
照射增加了 ONS 评分和瘙痒,而皮肤水分和 TEWL 则减少。主要假设是,在治疗 8 天后,与未治疗组相比,乳液治疗组的皮肤水分增加更为显著,但这一假设无法得到证实。然而,在研究结束时(第 47 天±7 天),与未治疗组相比,治疗组的角质层水分恢复更为先进,几乎达到了对侧健康乳房皮肤的水平。ONS 评分和瘙痒也显示出乳液治疗组的优势。TEWL 在乳液治疗过程中没有显示出显著变化。治疗方案没有引起不良反应。
水包油乳剂治疗放射性皮炎耐受性良好,可增强角质层水分,改善临床指标,缓解瘙痒。